Tewksbury, MA, United States of America

Teresa Kowalczyk-Przewloka

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Teresa Kowalczyk-Przewloka

Introduction

Teresa Kowalczyk-Przewloka is a prominent inventor based in Tewksbury, MA (US). She has made significant contributions to the field of pharmacology, particularly in the development of targeted therapeutics. With a total of 10 patents to her name, her work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

One of her latest patents focuses on targeted therapeutics, which provides pharmacological compounds that include an effector moiety conjugated to a binding moiety. This innovative approach directs the effector moiety to a biological target of interest. The invention also encompasses compositions, kits, and methods, including therapeutic, diagnostic, and imaging applications. Another notable patent involves triazole compounds that modulate Hsp90 activity. This invention relates to substituted triazole compounds and methods for inhibiting Hsp90 activity in subjects, particularly for preventing or treating hyperproliferative disorders such as cancer.

Career Highlights

Throughout her career, Teresa has worked with notable companies in the pharmaceutical industry, including Synta Pharmaceuticals Corporation and Madrigal Pharmaceuticals, Inc. Her expertise in pharmacological research has positioned her as a valuable asset in the development of innovative therapeutic solutions.

Collaborations

Teresa has collaborated with esteemed colleagues, including Lijun Sun and Weiwen Ying, to advance her research and contribute to the scientific community.

Conclusion

Teresa Kowalczyk-Przewloka's innovative work in pharmacology and her numerous patents highlight her significant contributions to medical science. Her dedication to developing targeted therapeutics continues to pave the way for advancements in cancer treatment and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…